Ontology type: schema:ScholarlyArticle Open Access: True
2021-11-08
AUTHORSHaiyan Li, Zongwen Shuai
ABSTRACTTo evaluate the efficacy and safety of tocilizumab (TCZ) in the treatment of refractory Takayasu arteritis (TAK). Eleven refractory TAK patients treated with TCZ at the First Affiliated Hospital of Anhui Medical University between 2017 July and 2020 December were respectively analyzed. We also respectively analyzed the studies on TCZ efficacy in patients with TAK, from PubMed/MEDLINE, Elsevier Science Direct between January 2010 and April 2021. The median age of 11 patients was 34(19–46) years. After 3 months of TCZ, a significant drop was found in median NIH (3[2–5] at baseline vs 1[0–2] after 6 months; p < 0.05), ITAS-2010 score (8.5[6–11] vs 6[1–10]; p < 0.05). One (9%) patient experienced relapse during TCZ treatment. After withdrawal of TCZ, one patient (9%) underwent relapse and nine patients (81%) were spared of GC use. In literature review, a total of 211 patients (mean age 35 years) were analyzed, including 80 (38%) Chinese and 169 females (80%). Among the 211 patients, (154 patients) 73% achieved remission after the last infusion of TCZ; TAK relapsed in 6% of patients during TCZ treatment and 5% of the TCZ patients after the withdrawal of TCZ. A total of 95 types of adverse events were observed in the literature. Infection was the most common adverse effect, occurring in 50% of patients. TCZ could serve as an efficacious and safe agent for refractory TAK. More... »
PAGES884-894
http://scigraph.springernature.com/pub.10.1007/s00380-021-01981-1
DOIhttp://dx.doi.org/10.1007/s00380-021-01981-1
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1142439886
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/34750666
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antibodies, Monoclonal, Humanized",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Recurrence",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Takayasu Arteritis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, 230022, Hefei, China",
"id": "http://www.grid.ac/institutes/grid.412679.f",
"name": [
"Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, 230022, Hefei, China"
],
"type": "Organization"
},
"familyName": "Li",
"givenName": "Haiyan",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, 230022, Hefei, China",
"id": "http://www.grid.ac/institutes/grid.412679.f",
"name": [
"Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, 230022, Hefei, China"
],
"type": "Organization"
},
"familyName": "Shuai",
"givenName": "Zongwen",
"id": "sg:person.0623105737.61",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623105737.61"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s11046-004-5495-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011536925",
"https://doi.org/10.1007/s11046-004-5495-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13075-021-02529-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1138169894",
"https://doi.org/10.1186/s13075-021-02529-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13075-020-02311-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1130923476",
"https://doi.org/10.1186/s13075-020-02311-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrrheum.2010.82",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017664931",
"https://doi.org/10.1038/nrrheum.2010.82"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10067-020-05066-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1127472617",
"https://doi.org/10.1007/s10067-020-05066-8"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11547-019-01058-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1117617323",
"https://doi.org/10.1007/s11547-019-01058-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10067-020-05005-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1125452605",
"https://doi.org/10.1007/s10067-020-05005-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12026-021-09194-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1138732016",
"https://doi.org/10.1007/s12026-021-09194-4"
],
"type": "CreativeWork"
}
],
"datePublished": "2021-11-08",
"datePublishedReg": "2021-11-08",
"description": "To evaluate the efficacy and safety of tocilizumab (TCZ) in the treatment of refractory Takayasu arteritis (TAK). Eleven refractory TAK patients treated with TCZ at the First Affiliated Hospital of Anhui Medical University between 2017 July and 2020 December were respectively analyzed. We also respectively analyzed the studies on TCZ efficacy in patients with TAK, from PubMed/MEDLINE, Elsevier Science Direct between January 2010 and April 2021. The median age of 11 patients was 34(19\u201346) years. After 3 months of TCZ, a significant drop was found in median NIH (3[2\u20135] at baseline vs 1[0\u20132] after 6\u00a0months; p\u2009<\u20090.05), ITAS-2010 score (8.5[6\u201311] vs 6[1\u201310]; p\u2009<\u20090.05). One (9%) patient experienced relapse during TCZ treatment. After withdrawal of TCZ, one patient (9%) underwent relapse and nine patients (81%) were spared of GC use. In literature review, a total of 211 patients (mean age 35\u00a0years) were analyzed, including 80 (38%) Chinese and 169 females (80%). Among the 211 patients, (154 patients) 73% achieved remission after the last infusion of TCZ; TAK relapsed in 6% of patients during TCZ treatment and 5% of the TCZ patients after the withdrawal of TCZ. A total of 95 types of adverse events were observed in the literature. Infection was the most common adverse effect, occurring in 50% of patients. TCZ could serve as an efficacious and safe agent for refractory TAK.",
"genre": "article",
"id": "sg:pub.10.1007/s00380-021-01981-1",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1095887",
"issn": [
"0910-8327",
"1615-2573"
],
"name": "Heart and Vessels",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "37"
}
],
"keywords": [
"refractory Takayasu arteritis",
"Takayasu arteritis",
"TCZ treatment",
"safety of tocilizumab",
"patient experienced relapse",
"efficacy of tocilizumab",
"common adverse effects",
"First Affiliated Hospital",
"Anhui Medical University",
"PubMed/MEDLINE",
"Elsevier Science Direct",
"TCZ efficacy",
"underwent relapse",
"TCZ patients",
"experienced relapse",
"TAK patients",
"median age",
"adverse events",
"GC use",
"last infusion",
"retrospective study",
"Affiliated Hospital",
"tocilizumab",
"safe agent",
"patients",
"Medical University",
"literature review",
"adverse effects",
"Science Direct",
"arteritis",
"relapse",
"efficacy",
"treatment",
"withdrawal",
"total",
"significant drop",
"remission",
"review",
"MEDLINE",
"hospital",
"infusion",
"infection",
"months",
"age",
"scores",
"NIH",
"ITAS",
"study",
"females",
"safety",
"years",
"agents",
"Direct",
"events",
"effect",
"use",
"literature",
"types",
"University",
"drop"
],
"name": "Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review",
"pagination": "884-894",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1142439886"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00380-021-01981-1"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"34750666"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00380-021-01981-1",
"https://app.dimensions.ai/details/publication/pub.1142439886"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:31",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_899.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s00380-021-01981-1"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-01981-1'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-01981-1'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-01981-1'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-01981-1'
This table displays all metadata directly associated to this object as RDF triples.
196 TRIPLES
22 PREDICATES
103 URIs
87 LITERALS
16 BLANK NODES